Skip to main content

Advertisement

SpringerLink
Log in

The true value of the TRUE test for allergic contact dermatitis

  • Published:
Current Allergy and Asthma Reports Aims and scope Submit manuscript

Abstract

The development of the thin layer rapid use epicutaneous (TRUE) Test is a history of cooperation between scientists from academia and industry covering several disciplines: medicine, pharmaceutical chemistry, pharmacology, and statistics. The TRUE Test is today a patch test system with documented stability and allergen content. Allergens are incorporated in a dried-in-gel vehicle, which is coated onto a polyester backing to form a patch. Applied to the skin, the allergens are released when the gel becomes moisturized by transepidermal water. This may seem to be a simple technique, but its development required laborious research and solutions to stability and dosage problems. The test has been clinically standardized with serial dilution tests on sensitized patients and validated in comparative multicenter tests. The test is a significant step towards higher reliability of patch testing. Fifteen years of experience and critical investigations are discussed in this article, as are possible improvements such as expansion of the test with new allergens.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Fischer T, Rystedt I: False-positive, follicular and irritant patch test reactions to metal salts. Contact Dermatitis 1985, 12:93–98.

    Article  PubMed  CAS  Google Scholar 

  2. Fischer T, Maibach HI: Improved, but not perfect, patch testing. Am J Contact Dermat 1990, 1:73–90.

    Google Scholar 

  3. Matthies C, Lender K, Reinhold R: Standard requirements for the quality control of patch test allergens. Am J Contact Dermat 1993, 4:212–214.

    Google Scholar 

  4. Brod BA, Dailey AD, Fransway AF, et al.: To patch or not to patch: what is your threshold for patch testing? [clinical conference]. Am J Contact Dermat 1999, 10:94–97.

    Article  PubMed  CAS  Google Scholar 

  5. Moore J: Patch testing practices: ACDS members. Am J Contact Dermat 2000, 11:128.

    Google Scholar 

  6. Warshaw EM: US Dermatologists’ approach to patch testing. Am J Contact Dermat 2000, 11:134.

    Google Scholar 

  7. Fischer T, Maibach HI: The thin layer rapid use epicutaneous test (TRUE-test), a new patch test method with high accuracy. Br J Dermatol 1985, 112:63–68.

    Article  PubMed  CAS  Google Scholar 

  8. Fischer T: Design considerations for patch testing. J Am Acad Dermatol 1994, 5:70–75.

    Google Scholar 

  9. Fischer T, Maibach HI: Easier patch testing with TRUE-Test. J Am Acad Dermatol 1989, 20:447–453.

    Article  PubMed  CAS  Google Scholar 

  10. Fischer T, Maibach HI: Antigen preparation for the patch test. Occup Med 1986, 1:343–348.

    PubMed  CAS  Google Scholar 

  11. Fischer T, Maibach HI: Patch testing in allergic contact dermatitis. In Exogenous Dermatoses: Environmental Dermatitis. Edited by Menné TMH. Johnstown: CTC Press; 1991:85–102.

    Google Scholar 

  12. Weibel H, Hansen J: Penetration of the fragrance compounds, cinnamaldehyde and cinnamyl alcohol, through human skin in vitro. Contact Dermatitis 1989, 20:167–172.

    Article  PubMed  CAS  Google Scholar 

  13. Weibel H, Hansen J: Interaction of cinnamaldehyde (a sensitizer in fragrance) with protein. Contact Dermatitis 1989, 20:161–166.

    Article  PubMed  CAS  Google Scholar 

  14. Weibel H, Hansen J, Andersen KE: Cross sensitization patterns in guinea pigs between cinnamaldehyde, cinnamyl alcohol and cinnamic acid. Acta Derm Venereol 1989: 302–307.

  15. Hoeck U, Kreilgård B: The role of pharmaceutical considerations on the choice of allergen in a standard series for patch testing. Am J Contact Dermat 1996, 7:60.

    Article  Google Scholar 

  16. Kreilgård B, Hoech U, Fransson D: What is the composition of the thiuram mix? Am J Contact Dermat 1995, 6:58.

    Article  Google Scholar 

  17. Kreilgård B, Møllgaard B, Hoech U: Pharmaceutical and clinical aspects of p-pheneylenediamine patch test material. Am J Contact Dermat 1996, 7:61.

    Article  Google Scholar 

  18. Kreilgård B, Hansen J, Fischer T: Chemical, pharmaceutical and clinical standardization of the TRUE Test caine mix. Contact Dermatitis 1989, 21:23–27.

    Article  PubMed  Google Scholar 

  19. Kreilgård B, Hansen J: Aspects of pharmaceutical and chemical standardization of patch test materials. J Am Acad Dermatol 1989, 21:836–838.

    PubMed  Google Scholar 

  20. Hansen J: Technology of allergen delivery. In Exogenous Dermatoses: Environmental Dermatitis. Edited by Menné TMH. Johnstown: CTC Press; 1991:151–164.

    Google Scholar 

  21. Albrechtsen S, Hansen J, Hedegaard K: b-cyclodextrin formaldehyde complex in patch testing of formaldehyde allergy. In Current Topics in Contact Dermatitis. Edited by Frosch P, Dooms-Goosens A, Lachapelle JM, et al. New York: Springer- Verlag; 1989:535–539.

    Google Scholar 

  22. Hansen J, Albrechtsen S, Hedegaard K: Proallergens of formaldehyde applied in patch testing of formaldehyde contact allergy. J Am Acad Dermatol 1989, 21:838–840.

    PubMed  CAS  Google Scholar 

  23. Hoeck U, Kreilgård B: Use of in vitro permeation studies to predict in vivo contact allergic cross-reactions from formaldehyde releasing biocides. In Prediction of Percutaneous Penetration vol 4b. Edited by Brain KR, James VJ, Walters KA. New York: Marcel Dekker; 1996:232–235.

    Google Scholar 

  24. Fischer T, Andersen KE, Bengtsson U, et al.: Clinical standardization of the TRUE Test formaldehyde patch. Curr Probl Dermatol 1995, 22:24–30.

    PubMed  CAS  Google Scholar 

  25. Matthies C, Dooms-Doosens A, Lachapelle JM, et al.: Patch testing with fractionated balsam of Peru. Contact Dermatitis 1988, 19:384–385.

    Article  PubMed  CAS  Google Scholar 

  26. Frankild S, Lepoittevin JP, Kreilgård B, Andersen KE: Tixocortol pivalate contact allergy in the GPMT: frequency and cross-reactivity. Contact Dermatitis 2001, 44:18–22.

    Article  PubMed  CAS  Google Scholar 

  27. Fischer T, Maibach HI, Hansen J, Kreilgård B: The science of patch test standardization. In Immunology and Allergy Clinics of North America vol 9. Edited by Maibach HI. Philadelphia: WB Saunders; 1989:417–434.

    Google Scholar 

  28. Ruhnek-Forsbeck M, Fischer T, Meding B, et al.: Comparative multi-center study with TRUE Test and Finn Chamber Patch Test methods in eight Swedish hospitals. Acta Derm Venereol 1988, 68:123–128.

    PubMed  CAS  Google Scholar 

  29. Ruhnek-Forsbeck M, Fischer T, Meding B, et al.: Comparative multi-center study with TRUE Test and Finn Chamber Patch Test methods in eight Swedish hospitals. J Am Acad Dermatol 1989, 21:846–849.

    Google Scholar 

  30. Stenberg B, Billberg K, Fischer T, et al.: Swedish multicenter study with TRUE Test Panel 2. In Current Topics in Contact Dermatitis. Edited by Frosch P, Dooms-Goossens A, Lachapelle JM, et al. New York: Springer-Verlag; 1989:518–523.

    Google Scholar 

  31. Wilkinson JD, Bruynzeel DP, Ducombs G, et al.: European multicenter study of TRUE Test, Panel 2. Contact Dermatitis 1990, 22:218–225.

    Article  PubMed  CAS  Google Scholar 

  32. Lachapelle JM, Bruynzeel DP, Ducombs G, et al.: European multicenter study of the TRUE Test. Contact Dermatitis 1988, 19:91–97.

    Article  PubMed  CAS  Google Scholar 

  33. Andersen KE, Svensson L, Fischer T, Gunnarsson Y: Experience with n-hydroxymethyl succinimide (HMS) in TRUE Test patches for the diagnosis of formaldehyde contact allergy. Contact Dermatitis 1990, 23:291.

    Article  Google Scholar 

  34. Rietschel RL, Marks JG, Adams RM, et al.: Preliminary studies of the TRUE Test patch test system. J Am Acad Dermatol 1989, 21:841–843.

    Article  Google Scholar 

  35. Gollhausen R, Przybilla B, Ring J: Reproducibility of patch test results: comparison of TRUE Test and Finn Chamber tests. J Am Acad Dermatol 1989, 21:843–846.

    PubMed  CAS  Google Scholar 

  36. Ayala F, Balato N, Lembo G, et al.: Italian multicenter study on Epiquick, Rapid patch Test and TRUE Test. J Eur Acad Dermatol Venereol 1994, 3:511–517.

    Article  Google Scholar 

  37. Fernandez-Vozmediano JM, Armario-Hita JC: Concordance and discordance between TRUE Test and Finn Chamber. Contact Dermatitis 2000, 42:182–183.

    PubMed  CAS  Google Scholar 

  38. Goh CL: Comparative study of TRUE Test and Finn Chamber patch test techniques in Singapore. Contact Dermatitis 1992, 27:84–89.

    Article  PubMed  CAS  Google Scholar 

  39. Fernandez-Vozmediano JM, Gil-Tocados G, Manrique-Plaza A: Comparison of TRUE Test and Finn Chambers in construction workers. Contact Dermatitis 1993, 28:244–245.

    Article  PubMed  CAS  Google Scholar 

  40. Prue C, Martinson ME, McAnally PM, Stagner WC: Postmarketing survey results of T.R.U.E. TEST, a new allergen patch test. Am J Contact Dermat 1998, 9:6–10.

    Article  PubMed  CAS  Google Scholar 

  41. Trattner A, David M: The concordance of TRUE test applied in reverse directions on either side of the back. Contact Dermatitis 1998, 39:137–138.

    Article  PubMed  CAS  Google Scholar 

  42. Andersen KE, Lidén C, Hansen J, Vølund Å: Dose response testing with nickel sulphate using the TRUE Test in nickel sensitive individuals: multiple nickel sulphate patch-test reactions do not cause an "angry back." Br J Dermatol 1993, 129:50–56.

    Article  PubMed  CAS  Google Scholar 

  43. Brasch J, Kreilgård B, Henseler T, et al.: Positive nickel patch tests do not intensify positive reactions to adjacent patch tests with dichromate. Contact Dermatitis 2000, 43:144–149.

    Article  PubMed  CAS  Google Scholar 

  44. Kalimo K, Lammintausta K: Nickel bioavailability from patch tests: comparison between nickel sulphate and nickel chloride. In Current Topics in Contact Dermatitis. Edited by Frosch P, Dooms-Goossens A, Lachapelle JM, et al. New York: Springer-Verlag; 1989:540–543.

    Google Scholar 

  45. Bygum A, Andersen KE: Persistent reactions after patch testing with TRUE Test panels 1 and 2. Contact Dermatitis 1998, 38:218–220.

    Article  PubMed  CAS  Google Scholar 

  46. Bjarnason B, Fischer T: Objective assessment of nickel sulfate patch test reactions with laser Doppler perfusion imaging. Contact Dermatitis 1998, 38:112–118. This investigation concerned optimal dose, time of application and test evaluation, and intensity profiles of patch test reactions evaluated with serial dilution on sensitive patients, visually and with a laser Doppler perfusion imaging technique.

    Article  Google Scholar 

  47. Bjarnason B, Fischer T: Visual and laser Doppler perfusion scanning assessments of Kathon CG patch test reactions. Am J Contact Dermat 1998, 9:224–230. This investigation concerned optimal dose, time of application and test evaluation, and intensity profiles of patch test reactions evaluated with serial dilution on sensitive patients, visually and with a laser Doppler perfusion imaging technique.

    Article  PubMed  CAS  Google Scholar 

  48. Bjarnason B, Flosadóttir E, Fischer T: Assessment of budesonide patch tests. Contact Dermatitis 1999, 41:211–217. This investigation concerned optimal dose, time of application and test evaluation, and intensity profiles of patch test reactions evaluated with serial dilution on sensitive patients, visually and with a laser Doppler perfusion imaging technique.

    Article  PubMed  CAS  Google Scholar 

  49. Bjarnason B, Flosadóttir E: Patch testing with neomycin sulfate. Contact Dermatitis 2000, 43:295–302. This investigation concerned optimal dose, time of application and test evaluation, and intensity profiles of patch test reactions evaluated with serial dilution on sensitive patients, visually and with a laser Doppler perfusion imaging technique.

    Article  PubMed  CAS  Google Scholar 

  50. Bjarnason B, Flosadóttir E, Fischer T: Assessment of balsam of Peru patch tests. Contact Dermatitis 2000, 42:326–329. This investigation concerned optimal dose, time of application and test evaluation, and intensity profiles of patch test reactions evaluated with serial dilution on sensitive patients, visually and with a laser Doppler perfusion imaging technique.

    Article  PubMed  CAS  Google Scholar 

  51. Jacobs JL, Brancaccio R, Belsito DV, Cohen DE: Utility of standard allergen series alone in the evaluation of allergic contact dermatitis: a retrospective study of 1662 patients. J Am Acad Dermatol 1999, 10:113.

    Google Scholar 

  52. Katz AS, Sherertz EF: Facial dermatitis: patch test results and final diagnoses. Am J Contact Dermat 1999, 10:153–156.

    Article  PubMed  CAS  Google Scholar 

  53. Lachapelle JM, Ale SI, Freeman S, et al.: Proposal for a revised international standard series of patch tests. Contact Dermatitis 1997, 36:121–123.

    Article  PubMed  CAS  Google Scholar 

  54. Maibach HI: The ESS—excited skin syndrome (alias the angry back). In New Trends in Allergy. Edited by Ring J, Burg G. New York: Springer; 1981:208–211.

    Google Scholar 

  55. Surakka J, Lindh T, Rosén G, Fischer T: Workers’ dermal exposure to UV-curable acrylates in the furniture and parquet industry. Ann Occup Hyg 2000, 44:635–644. This article presents a seldom-used, high-quality technique for determining relevant exposure to allergens.

    PubMed  CAS  Google Scholar 

  56. Lachapelle JM: A proposed relevance scoring system for positive allergic patch test reactions: practical implications and limitations. Contact Dermatitis 1997, 36:39–43.

    Article  PubMed  CAS  Google Scholar 

  57. Ale I, Maibach HI: Operational definition of occupational allergic contact dermatitis. In Handbook of Occupational Dermatology. Edited by Kanerva L, Elsner P, Wahlberg JE, Maibach HI. New York: Springer; 2000:344–350.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, University of California-San Francisco School of Medicine, Surge 100, Box 0889, 04143-0989, San Francisco, CA, USA

    Torkel Fischer MD, Bo Kreilgård PhD & Howard I. Maibach MD

Authors
  1. Torkel Fischer MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bo Kreilgård PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Howard I. Maibach MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fischer, T., Kreilgård, B. & Maibach, H.I. The true value of the TRUE test for allergic contact dermatitis. Curr Allergy Asthma Rep 1, 316–322 (2001). https://doi.org/10.1007/s11882-001-0042-2

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11882-001-0042-2

Keywords

Search

Navigation